UAB Division of Cardiothoracic Surgery Assistant Professor Panayotis Vardas, M.D., has co-authored the article, "The Society of Thoracic Surgeons 2023 clinical practice guidelines for the surgical ...
LONDON — Updated guidelines for the management of atrial fibrillation released by the European Society of Cardiology are revamping the approach to care for this complex, multifactorial disease. The ...
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced it expanded its Phase III OCEANIC clinical development program for the investigational drug asundexian (BAY2433334) by initiating a third ...
The second focused update endorses dabigatran (Pradaxa), a new drug that like warfarin represents a first-line choice to prevent thromboembolism in AF. 2 The FDA approved dabigatran in October 2010.
Announcing a new article publication for Cardiovascular Innovations and Applications journal. Atrial fibrillation is the most common arrhythmia worldwide, affecting millions of the general population.
We conducted an international, open-label, randomized, blinded-outcome-assessment trial involving 1284 patients who had undergone successful catheter ablation for atrial fibrillation at least 1 year ...
Recent advances in the diagnosis and treatment of atrial fibrillation, and what they mean for patients, were considered by a group of around 75 international experts at a three-day meeting that began ...
Device-detected atrial high-rate episodes (AHREs) are atrial arrhythmias detected by implanted cardiac devices. AHREs resemble atrial fibrillation but are rare and brief. Whether the occurrence of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results